Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Leblanc

Showing results (51-60 of 155) with videos related to

Pageof 16
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2016
Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical TrialsHeather Greenlee, Joseph M Unger, Michael LeBlanc, et al.
Journal of the National Cancer Institute|December 5, 2025
Development and validation of a risk prediction model for acute care use among older advanced cancer patients on clinical trialsDawn L Hershman, Cathee Till, Michael Leblanc, et al.
JAMA Oncology|August 17, 2023
Medicaid Expansion of the Patient Protection and Affordable Care Act and Participation of Patients With Medicaid in Cancer Clinical TrialsJoseph M Unger, Hong Xiao, Riha Vaidya, et al.
JAMA Network Open|July 29, 2021
Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 PandemicJoseph M Unger, Hong Xiao, Michael LeBlanc, et al.
Biometrics|September 30, 2017
Case-only approach to identifying markers predicting treatment effects on the relative risk scaleJames Y Dai, C Jason Liang, Michael LeBlanc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2013
Modeling the relationship between progression-free survival and overall survival: the phase II/III trialMary W Redman, Bryan H Goldman, Michael LeBlanc, et al.
Human Molecular Genetics|September 10, 2002
Evaluating test statistics to select interesting genes in microarray experimentsCharles Kooperberg, Simonetta Sipione, Michael LeBlanc, et al.
The Canadian Journal of Hospital Pharmacy|July 8, 2026
Perspectives on Leadership Development and Learning Needs of Pharmacy Leaders in Canadian Health Care Systems: A Qualitative StudyHeather Naylor, Wooje Choi, Michael LeBlanc, et al.
Nature Communications|January 28, 2015
Probing failure susceptibilities of earthquake faults using small-quake tidal correlationsBraden A W Brinkman, Michael LeBlanc, Yehuda Ben-Zion, et al.
Physical Review. E|December 15, 2016
Avalanche statistics from data with low time resolutionMichael LeBlanc, Aya Nawano, Wendelin J Wright, et al.
Pageof 16

Showing results (51-60 of 155) with videos related to

Sort By:
Pageof 16
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 18, 2016
Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical TrialsHeather Greenlee, Joseph M Unger, Michael LeBlanc, et al.
Journal of the National Cancer Institute|December 5, 2025
Development and validation of a risk prediction model for acute care use among older advanced cancer patients on clinical trialsDawn L Hershman, Cathee Till, Michael Leblanc, et al.
JAMA Oncology|August 17, 2023
Medicaid Expansion of the Patient Protection and Affordable Care Act and Participation of Patients With Medicaid in Cancer Clinical TrialsJoseph M Unger, Hong Xiao, Riha Vaidya, et al.
JAMA Network Open|July 29, 2021
Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 PandemicJoseph M Unger, Hong Xiao, Michael LeBlanc, et al.
Biometrics|September 30, 2017
Case-only approach to identifying markers predicting treatment effects on the relative risk scaleJames Y Dai, C Jason Liang, Michael LeBlanc, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2013
Modeling the relationship between progression-free survival and overall survival: the phase II/III trialMary W Redman, Bryan H Goldman, Michael LeBlanc, et al.
Human Molecular Genetics|September 10, 2002
Evaluating test statistics to select interesting genes in microarray experimentsCharles Kooperberg, Simonetta Sipione, Michael LeBlanc, et al.
The Canadian Journal of Hospital Pharmacy|July 8, 2026
Perspectives on Leadership Development and Learning Needs of Pharmacy Leaders in Canadian Health Care Systems: A Qualitative StudyHeather Naylor, Wooje Choi, Michael LeBlanc, et al.
Nature Communications|January 28, 2015
Probing failure susceptibilities of earthquake faults using small-quake tidal correlationsBraden A W Brinkman, Michael LeBlanc, Yehuda Ben-Zion, et al.
Physical Review. E|December 15, 2016
Avalanche statistics from data with low time resolutionMichael LeBlanc, Aya Nawano, Wendelin J Wright, et al.
Pageof 16